[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fO8Vr8oD9UO2KJrgSbXJmXD0-P1LKIJhixtdzPQ2SOYM":3},{"answer":4,"createTime":5,"id":6,"options":7,"origin":13,"question":20,"related":21,"source":32,"type":33},[],"2026-05-21 09:43:43",380394918,[8,9,10,11,12],"全血","悬浮红细胞","单采血小板","新鲜冰冻血浆","冷沉淀",{"count":14,"courseId":15,"courseImg":16,"courseName":17,"workId":18,"workName":19},81,"295476882842784d91dfca0a2d29c368","https:\u002F\u002Ftihai-oss-cloud.itihey.com\u002Fimg\u002F10baf5bc3eee9ea2707da3b904acb974.jpg","临床输血学检验技术","work_53422318","临床输血与自体输血(2026)","输血申请单中输血目的为纠正贫血,申请备血的血液成分应为( )",[22,34,42,52,58,68,74,80,90,100],{"answer":23,"createTime":5,"id":24,"options":25,"question":31,"source":32,"type":33},[],380394903,[26,27,28,29,30],"临床上有效且能够提供最大安全性的血细胞","临床上有效且能够提供最大安全性的血浆","临床上有效且能够提供最大安全性的血浆制品","虽然不是最安全,但临床上有效的某一种血液成分","临床上有效且能够提供最大安全性的某一种血液成分","患者应该尽可能只接受( )","v1",0,{"answer":35,"createTime":5,"id":36,"options":37,"question":41,"source":32,"type":33},[],380394904,[8,9,38,39,40],"洗涤红细胞","少白细胞红细胞","辐照红细胞","患者女,32岁.因贫血需输血治疗,实验室检查结果为RBC 1.6×10¹2\u002FL,Hb 52g\u002FL,HCt 15.4%,既往史显示患者曾对血浆蛋白有过敏反应.此患者应输何种血液成分( )",{"answer":43,"createTime":5,"id":44,"options":45,"question":51,"source":32,"type":33},[],380394906,[46,47,48,49,50],"输注红细胞","输注全血","祛除病因","补充铁剂","补充VitC","缺铁性贫血患者首选的治疗方案是( )",{"answer":53,"createTime":5,"id":54,"options":55,"question":57,"source":32,"type":33},[],380394907,[8,11,56,12,9],"VIⅢ因子浓缩剂","血管性血友病患者,补充vWF应选择( )",{"answer":59,"createTime":5,"id":60,"options":61,"question":67,"source":32,"type":33},[],380394909,[62,63,64,65,66],"治疗疾病","缓解贫血症状","提高血红蛋白值达到正常水平","提高血细胞比容达到正常水平","提高机体免疫力","慢性贫血输注悬浮红细胞的主要目的是( )",{"answer":69,"createTime":5,"id":70,"options":71,"question":73,"source":32,"type":33},[],380394910,[8,9,40,38,72],"低温保存红细胞","有免疫缺陷或免疫抑制的患者需输注红细胞制剂时,应尽量输注( )",{"answer":75,"createTime":5,"id":76,"options":77,"question":79,"source":32,"type":33},[],380394912,[9,78,39,8,38],"辐照悬浮红细胞","血红蛋白低于60g\u002FL的慢性贫血患者,输血治疗时通常选择( )",{"answer":81,"createTime":5,"id":82,"options":83,"question":89,"source":32,"type":33},[],380394914,[84,85,86,87,88],"急性白血病患者","慢性白血病患者","特发性血小板减少性紫癜患者","DIC患者","急性再生障碍性贫血患者","输注冷沉淀的主要适应证是( )",{"answer":91,"createTime":5,"id":92,"options":93,"question":99,"source":32,"type":33},[],380394915,[94,95,96,97,98],"外周血粒细胞计数增加","患者体温正常","患者尿量增加","患者体温下降,感染被控制","血压升高","临床输注粒细胞有效的判断标准是( )",{"answer":101,"createTime":5,"id":6,"options":102,"question":20,"source":32,"type":33},[],[8,9,10,11,12]]